Advertisement

Do These Words From Moderna's President Mean Trouble for Vaccine Makers?

Do These Words From Moderna's President Mean Trouble for Vaccine Makers?

One of the biggest topics these days among coronavirus investors is vaccine efficacy. In fact, the president of vaccine maker Moderna (NASDAQ: MRNA) recently made a comment about how the variant is changing the vaccine landscape. Do these words from Moderna president Stephen Hoge signal difficult times ahead for vaccine makers?